Parent-Mediated Intervention for Autism Spectrum Disorder
(PRIMeR Trial)
Trial Summary
What is the purpose of this trial?
This trial tests two therapies for young children with autism who haven't responded well to usual treatments. The therapies involve parents playing with their children to encourage communication and social skills. One therapy focuses on general improvement, while the other targets specific weaknesses.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
What data supports the effectiveness of the treatment PRIMeR for autism spectrum disorder?
Research shows that Pivotal Response Treatment (PRT), a key component of PRIMeR, is effective in improving communication and social skills in children with autism. Studies indicate that parents trained in PRT can help increase their children's speech and social interactions, making it a promising approach for autism treatment.12345
Is parent-mediated intervention for autism spectrum disorder safe for humans?
The studies reviewed focus on the effectiveness of parent-mediated interventions like Pivotal Response Treatment (PRT) and Natural Language Paradigm (NLP) for improving communication in children with autism. They do not report any safety concerns, suggesting these interventions are generally safe for use in humans.12367
How is the Parent-Mediated Intervention for Autism Spectrum Disorder treatment different from other treatments?
This treatment is unique because it involves training parents to use Pivotal Response Treatment (PRT) techniques at home, focusing on improving communication and social skills in a natural play environment. It empowers parents to actively participate in their child's therapy, which can lead to increased speech and social interaction in children with autism.12368
Research Team
Isabel M Smith, PhD
Principal Investigator
IWK Health Centre and Dalhousie University
Eligibility Criteria
This trial is for preschoolers with autism spectrum disorder in Nova Scotia who show minimal response to standard treatments. They should have limited positive emotions, use fewer than 10 words spontaneously, and be about to enroll in the NS EI program. Children with severe sensory or motor impairments or whose parents can't consent in English are excluded.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Virtual Parent-Coaching Intervention
Parents receive virtual coaching in either PRIMeR or PRT strategies to enhance child responsivity
Follow-up
Participants are monitored for gains in social initiations and communication levels
Treatment Details
Interventions
- PRIMeR (Behavioural Intervention)
- PRT (Behavioural Intervention)
PRIMeR is already approved in Canada, China for the following indications:
- Autism Spectrum Disorder (ASD)
- Autism Spectrum Disorder (ASD)
Find a Clinic Near You
Who Is Running the Clinical Trial?
IWK Health Centre
Lead Sponsor
Dr. Doug Sinclair
IWK Health Centre
Chief Medical Officer
MD from Dalhousie University
Dr. Krista Jangaard
IWK Health Centre
Chief Executive Officer since 2018
MD and Masters of Health Administration from Dalhousie University
Canadian Institutes of Health Research (CIHR)
Collaborator
Dr. Paul C. Hébert
Canadian Institutes of Health Research (CIHR)
Chief Executive Officer
MD, University of Ottawa
Dr. Paul C. Hébert
Canadian Institutes of Health Research (CIHR)
Chief Medical Officer
MD, University of Ottawa